Durable Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks Over 128 Weeks in Patients with Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2, and CIMPACT). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s81, 2020. DOI: 10.25251/skin.4.supp.81. Disponível em: https://skin.dermsquared.com/skin/article/view/1114. Acesso em: 8 jun. 2025.